BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 12889078)

  • 1. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
    Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
    Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
    J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease.
    Haensch CA; Lerch H; Jörg J; Isenmann S
    Parkinsonism Relat Disord; 2009 Feb; 15(2):134-7. PubMed ID: 18515170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
    Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
    J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
    Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W
    Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
    Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B
    J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease.
    Mitsui J; Saito Y; Momose T; Shimizu J; Arai N; Shibahara J; Ugawa Y; Kanazawa I; Tsuji S; Murayama S
    J Neurol Sci; 2006 Apr; 243(1-2):101-4. PubMed ID: 16442563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.
    Braune S; Reinhardt M; Bathmann J; Krause T; Lehmann M; Lücking CH
    Acta Neurol Scand; 1998 May; 97(5):307-14. PubMed ID: 9613560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
    Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
    Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
    Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
    Kim JS; Lee PH; Lee KS; Park JW; Kim YI; Chung YA; Kim SH; Kim SH; Kim J; Choi YY; Kim HT
    Mov Disord; 2006 Nov; 21(11):1990-4. PubMed ID: 16991157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
    Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
    J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
    Reinhardt MJ; Jüngling FD; Krause TM; Braune S
    Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.